HD-OPM Archive
Topics › Infections & vaccines

Fluvoxamine reduced fatigue in Long COVID; metformin did not

Louis Nervegna · Apr 06, 2026 · ♥ 2 reactions · 1 comments · original Facebook post
Infections & vaccines
AI summary & key facts

Louis shares an Annals of Internal Medicine report that fluvoxamine significantly reduced fatigue in Long COVID while metformin did not, and notes fluvoxamine's early COVID promise was not confirmed by better trials.

The anti-depressant fluvoxamine significantly reduces fatigue in people with Long Covid.

(Metformin does not.)

As a side note:

There was a lot hope during the pandemic that fluvoxamine would successfully treat Covid. Early on, a promising randomized trial suggested that it did. This attracted lot of attention at the time, given that no other treatments existed. But higher quality studies, done later on, ultimately showed that it did not work.

(I was one of the early people who took fluvoxamine off-label as a treatment for Covid, thinking it would help after that first randomized trial was published.)

So it’s very interesting to see fluvoxamine re-emerge here as a successful treatment for Long Covid.

#fluvoxamineHD #longcovidHD #fatigueHD #covidHD #metforminHD #metformincovidHD

Research cited

ICYMI: Researchers found that fluvoxamine, a widely used antidepressant, significantly reduced fatigue in people with #LongCOVID, while #metformin did not improve symptoms. The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID (Ann Intern Med, 2026)

No photo description available.
← newer: 50:50 salt and potassium chloride blend lowers sodium while older: ACC/ESC consensus statement on abnormal cardiovascular findi →